Medical Device Marketing: Agency vs In-House Team

Every growing medical device company hits this question eventually: should we build an in-house marketing team or hire a specialized agency? I run an agency, so you already know where my bias sits. But I have also watched enough device companies make both choices -- some brilliantly, some disastrously -- that I can give you an honest framework for making this decision yourself.

The truth is that there is no universally right answer. It depends on your revenue, your growth stage, the complexity of your product portfolio, and what you actually need marketing to do for you. What I can do is give you the real numbers, the honest trade-offs, and a decision framework that has held up across dozens of medtech companies I have worked with over 18 years.

The Real Cost of an In-House Marketing Team

Let us start with the number most device companies underestimate: what it actually costs to build a functional marketing team in-house. And I mean functional -- not one overwhelmed marketing coordinator trying to do the work of five people.

Here is what a lean but capable in-house team looks like in 2026, including salaries, benefits, payroll taxes, and typical overhead:

Those salary ranges include the full loaded cost -- base salary plus health insurance, 401k match, payroll taxes, PTO, and the other benefits you need to offer to attract competent people. The tools line covers your SEO platform, design software licenses, email marketing platform, CMS, analytics tools, and project management software. Some companies spend significantly more on tools.

But here is what the spreadsheet does not show you. Even with four people and half a million dollars in annual spend, you still do not have:

• Specialized medtech marketing expertise. Your digital marketing specialist probably came from B2B SaaS or consumer marketing. They do not know the difference between 510(k) clearance and PMA approval, and they have never written copy that needs to survive an MLR review.
• Conference marketing experience. Medical conferences have their own ecosystem -- booth design, pre-show campaigns, KOL management, post-show follow-up. Your in-house team is learning this from scratch every time.
• FDA compliance knowledge. One wrong claim on a brochure or website can trigger an FDA warning letter. Your in-house team needs either deep regulatory marketing training or constant oversight from your regulatory affairs team -- which creates its own bottleneck.
• Surge capacity. Product launches, trade shows, and campaign pushes all require bursts of capability. Your four-person team has a fixed capacity that cannot flex for these moments.

And then there is the hidden cost that nobody puts in the budget: management overhead. Somebody in your leadership team is now managing four marketers. That is hiring, performance reviews, career development, conflict resolution, and strategic direction -- on top of their existing job.

The Cost of a Specialized Agency

Now let us look at the other side of the ledger.

A specialized medical device marketing agency typically works on one of two models:

• Monthly retainers: $5,000 to $15,000 per month ($60,000 to $180,000 per year). This covers ongoing strategy, content, SEO, design, and campaign management with a dedicated team.
• Project-based: $10,000 to $75,000 per project. Website redesigns, product launches, trade show campaigns, and video production are common project engagements.

For that retainer, you get access to an entire team: strategist, graphic designer, copywriter, SEO specialist, web developer, video producer, and project manager. You are not paying for any of their benefits, tools, or management overhead. Those costs are baked into the retainer.

But the real advantage is not cost -- it is expertise density. A specialized medtech agency has worked with five, ten, maybe twenty other device companies. They have seen what works for surgical robotics companies and what fails for diagnostic imaging startups. They know which conferences matter for your specialty, how to structure an MLR-friendly content workflow, and what claims language will survive regulatory review.

That pattern recognition across the industry is something no in-house team can replicate, because your in-house team only ever works on your products.

What You Give Up with an Agency

Agencies are not perfect, and I would be dishonest if I did not acknowledge the trade-offs:

• You share their attention. Your agency has other clients. They are not sitting in your office thinking about your products eight hours a day. Good agencies mitigate this with dedicated account teams, but you are never their only priority.
• Ramp-up time. An agency needs three to six months to deeply understand your products, competitive landscape, and internal culture. The first quarter of any agency relationship produces less value than the second.
• Internal knowledge gaps. Your agency does not sit in your all-hands meetings or hear the hallway conversations about product direction. You need to actively feed them information, or they will operate with incomplete context.
• Less control over daily execution. You cannot walk over to your agency's desk and redirect their afternoon. Communication goes through channels, and there is inherent latency in external relationships.

When In-House Makes Sense

Despite running an agency, I will tell you honestly: some companies should build in-house. Here is when:

• Your revenue exceeds $50 million with established product lines. At this scale, you have enough marketing volume to keep a full team busy and enough budget to hire experienced medtech marketers. You also have the institutional complexity -- multiple business units, global markets, complex internal stakeholders -- that benefits from people who live inside the organization full-time.
• You need daily content output at volume. If your strategy requires daily social posts, weekly blog articles, bi-weekly emails, and constant sales collateral updates, the sheer volume of work may justify dedicated headcount. Agencies are better at quality and strategy than at raw production volume.
• Your internal approval workflows are complex enough to require someone embedded. Some device companies have MLR review processes that take weeks and require constant back-and-forth with regulatory, legal, and clinical teams. Having a marketer embedded in that process -- sitting in the same building, attending the same meetings -- can dramatically reduce cycle times.
• Long-term institutional knowledge is a competitive advantage. If you are a platform company with a 10-year product roadmap, the deep institutional knowledge that builds over years of in-house employment becomes genuinely valuable. An agency team member might leave or get reassigned; your in-house marketing director has been living your brand for five years.

When an Agency Makes Sense

An agency is typically the better choice in these situations:

• Your revenue is under $50 million or you are in startup or growth stage. You do not have the budget for a full team, and you need every marketing dollar to work as hard as possible. An agency gives you a complete team for the cost of one senior hire.
• You need specialized medtech expertise you cannot hire locally. Finding a marketing director with deep medical device experience, FDA compliance knowledge, and hands-on execution skills is extremely difficult. The talent pool is small and concentrated in a few cities. An agency has already assembled that team.
• Conference marketing is a major channel for you. This is where agencies genuinely shine. We see the whole landscape -- which booths work, which pre-show strategies drive meetings, which follow-up sequences convert. We attend dozens of medical conferences every year and bring that cross-industry perspective to every client.
• You are launching a new product. Launches require a burst of capability across every marketing discipline: messaging, website, content, SEO, trade show, sales enablement, email. An agency can spin up all of those workstreams simultaneously. Building an in-house team for a launch means hiring four people who might not have enough work six months after launch.
• You need strategic thinking and execution, not just hands. If your company needs someone to build the marketing strategy from scratch -- not just execute tasks -- a senior agency team brings strategic frameworks proven across multiple device companies. They have seen what works and what does not.

The Hybrid Model

Here is what most smart medical device companies actually do, and what I recommend to about 70 percent of the companies that call us.

Hire one strong marketing director in-house. This person owns the strategy, manages the internal stakeholders, sits in the leadership meetings, and serves as the bridge between the company and the agency. They do not need to execute everything -- they need to direct everything.

Then use an agency for execution: design, SEO, content production, video, conference marketing, website development. The agency brings the team, the tools, and the specialized expertise. Your marketing director brings the internal knowledge, the stakeholder relationships, and the strategic direction.

Compare that to $350,000 to $500,000 for a lean in-house team, and you are saving $40,000 to $180,000 per year while getting access to a broader range of expertise. Your marketing director is not trying to be the strategist, the writer, the designer, and the SEO specialist. They are directing a team of specialists.

The hybrid model also gives you flexibility. If you need to scale up for a product launch, you increase the agency scope for three months. If you need to cut costs during a lean quarter, you can reduce the retainer without laying anyone off. Try doing that with four W-2 employees.

Decision Framework

If you want a simple way to think through this decision, here are the four questions that matter most:

These are guidelines, not rules. A $15 million device company with 12 SKUs and a packed conference calendar might need the hybrid model. A $60 million company with one product and a direct-to-hospital sales model might do fine with a lean agency engagement. Context matters more than revenue thresholds.

What to Look for in a Medical Device Marketing Agency

If you decide an agency is the right move -- or the right complement to your in-house director -- here is what separates a good medtech agency from a generalist agency that will waste your money:

• Healthcare specialization. The agency should work primarily or exclusively with medical device, biotech, or healthcare companies. If their portfolio includes restaurants, law firms, and SaaS startups alongside your surgical robotics company, they do not have the depth you need.
• Experience with your device category. An agency that has marketed orthopedic implants understands the surgeon buyer journey, the VAC process, and the competitive landscape. That knowledge transfers directly to your engagement.
• Understanding of FDA marketing compliance. Ask them about their MLR review process. Ask them about the difference between cleared and approved. Ask them how they handle claims substantiation. If they cannot answer confidently, they will create compliance risk for your company.
• Conference marketing capability. If trade shows matter to you, the agency should have deep experience with booth design, pre-show campaigns, on-site execution, and post-conference follow-up strategies. This is not something you can fake.
• Referenceable medical device clients. Ask to speak with current and former clients. Any agency worth hiring will gladly connect you with references. If they hesitate, that tells you something.

The Cost of Getting It Wrong

The most expensive option is not in-house or agency. It is making the wrong choice and having to switch.

I have seen device companies spend $400,000 building an in-house team, realize after 18 months that their marketing director does not have medtech experience and their content is not surviving MLR review, fire the team, and come to an agency. That is $600,000 in salary and severance, plus 18 months of lost market opportunity. The opportunity cost alone dwarfs any difference in the in-house versus agency cost comparison.

I have also seen companies hire a generalist agency -- the kind that promises they can learn any industry -- and spend a year educating them about FDA compliance, clinical claims, and the hospital buying process. The agency bills $120,000, produces work that cannot be used because it does not meet regulatory standards, and the company starts over with a specialized firm.

Both mistakes are avoidable if you are honest about what you actually need and realistic about what each option can deliver.

Making the Transition

If you are currently doing marketing in-house and considering an agency -- or vice versa -- here is how to make the transition without losing momentum:

Moving from In-House to Agency

• Document everything. Brand guidelines, approved claims library, competitive intelligence, customer personas, campaign history. The more context you give the agency, the faster the ramp-up.
• Keep your marketing director. Even if you are outsourcing execution, you need someone in-house to manage the agency relationship, provide internal context, and ensure strategic alignment.
• Plan for a 90-day transition. Run both models in parallel for the first quarter. Let the agency shadow your current process before they take over execution.

Moving from Agency to In-House

• Hire before you fire. Do not cancel the agency until your in-house team is hired, onboarded, and producing work. The gap between agency and in-house is where campaigns die.
• Get the institutional knowledge transferred. Have the agency document every active campaign, every content calendar, every SEO strategy, every analytics setup. This knowledge walks out the door when the agency engagement ends.
• Budget for the learning curve. Your new in-house team will be less productive than the agency for the first six months. They are learning your products, your audience, and your processes from scratch.

The Honest Answer

We are obviously biased. We built this agency specifically for medical device companies because we believe that specialized expertise, cross-industry pattern recognition, and team flexibility deliver better outcomes for most device companies than a comparable in-house investment.

But "most" is not "all." If you are a large, established device company with the budget and the talent pipeline to build a world-class in-house team, you should do that. If you are a growth-stage company that needs every dollar to work hard and every campaign to be informed by deep medtech expertise, an agency -- or the hybrid model -- will serve you better.

The worst thing you can do is make this decision based on ego ("we should own our marketing") or inertia ("we have always used an agency") instead of an honest assessment of your needs, your budget, and your competitive reality.

Whatever you decide, make sure the people doing your marketing understand medical devices. That is the one non-negotiable. A brilliant generalist marketer who does not understand FDA compliance, clinical evidence hierarchies, and the hospital procurement process will produce work that either cannot be used or actively creates risk for your company. Medtech marketing is its own discipline, and it demands specialists -- whether those specialists sit in your office or in ours.